Medical Devices

March 15, 2013

Buy ($175)

Topics covered: Orthopedics and Cardiovascular Medical Devices, Medical Device Innovation and Consolidation Trends, Health Care, Cardiac, Affordable Care Act

Companies covered: Atossa Genetics Inc. (NASDAQ:ATOS), NeuroMetrix, Inc. (NASDAQ:NURO), Thoratec Corporation (NASDAQ:THOR), Medtronic, Inc. (NYSE:MDT), MAKO Surgical Corp., Integra LifeSciences Holdings Corporation (NASDAQ:IART), Heartware International, Inc. (NASDAQ:HTWR), Endologix, Inc. (NASDAQ:ELGX), Zimmer Holdings, Inc. (NYSE:ZMH), Wright Medical Group, Inc. (NASDAQ:WMGI), Stryker Corporation (NYSE:SYK), Smith & Nephew SNATS, Inc. (NYSE:SNN), Johnson & Johnson (NYSE:JNJ), Intuitive Surgical, Inc. (NASDAQ:ISRG), Baxter International Inc. (NYSE:BAX), Covidien Ltd. (NYSE:COV), Cooper Companies, Inc. (The) (NYSE:COO), Boston Scientific Corporation (NYSE:BSX), Abbott Laboratories (NYSE:ABT)